FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and specifically to a method of producing parvovirus derived from an unconjugated cell culture supernatant. Method comprises (a) a pre-calculation step every 24 hours of a time-dependent change in cell density in a culture substrate, when host cells are infected with parvovirus for each cell density (A) when infected with a virus; (b) a step for determining, based on the time-dependent change in cell density, calculated at step (a), (b1), the time (Tmax) from infection to time of peak time-dependent change in cell density, (b2) cell density (Bmax) at Tmax and A1, which is A, which satisfies following equation (1) Bmax/A1>1.2, (b3) maximum (Amax) cell density A1 when infected with virus and (b4) A2, which satisfies following equation (2) Amax≥A2≥Amax/10; (c) a stage of inoculation of seed parvovirus into a culture substrate containing host cells having cell density A2, wherein the infecting virus defined in (b4) of step (b) and the serum medium give a multiplicity of infection (MOI) of 0.001 to 0.1; (d) a cultivation stage of a cultured product containing host cells and parvovirus obtained at step (c) for a period of time Tmax or more to less than (Tmax+48) hours, where Tmax is defined in (b1) of step (b); (e) a step for replacing the culture supernatant obtained in step (d) with a serum-free medium and culturing for 12 hours or more; and (f) a step for collecting a parvovirus-containing culture supernatant produced by culturing at step (e); where at step (b), when A satisfying equation (1) is absent, steps (a) and (b) are repeated by using another density of cells A when infected with virus.
EFFECT: invention enables to obtain parvovirus with high infectivity titre for use in evaluating viral safety of pharmaceutical or biological products or when producing vaccines.
9 cl, 10 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MAKING RECOMBINANT ADENOVIRUS PREPARATION CHARACTERISED BY LOWER RATIO OF PHYSICAL AND INFECTIOUS VIRAL PARTICLES, AND GENETICALLY THERAPEUTIC DRUG PREPARATION PRODUCED BY SUCH METHOD | 2009 |
|
RU2443779C2 |
METHOD FOR VIRUS REPLICATION IN AVIAN EMBRYO STEM CELLS | 2006 |
|
RU2457253C2 |
METHOD OF PRODUCING MATERIAL WITH HIGH TITRE OF HEPATITIS E VIRUS AND ANALYSIS OF HEPATITIS E VIRUS TITRATION | 2016 |
|
RU2691123C1 |
TWO-STAGE TEMPERATURE PROFILE OF VIRAL CULTIVATION | 2008 |
|
RU2476594C2 |
METHOD FOR CULTIVATION OF PIG FETAL LARYNX CELLS FOR VIROLOGY | 2023 |
|
RU2827170C1 |
METHOD OF OPTIMIZING LARGE-SCALE PRODUCTION OF PARVOVIRUS H-1 IN SUBSTANTIALLY SERUM-FREE MEDIUM | 2017 |
|
RU2714111C1 |
METHODS FOR RELEASE OF VIRUS-LIKE PARTICLES | 2014 |
|
RU2648143C2 |
ANTIVIRAL COMPOSITION | 2012 |
|
RU2584245C2 |
METHOD OF PROTEIN EXPRESSION | 2007 |
|
RU2486236C2 |
METHOD OF PRODUCING CONTINUOUS CELL LINES AND USE THEREOF | 2009 |
|
RU2509803C2 |
Authors
Dates
2019-10-02—Published
2016-10-05—Filed